ConductScience.org, home

Paper20008845

Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Toole BP. Clin Cancer Res, 2009. Cited by 295 papers, by iCite.

Cite this record

ConductScience Library. Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Papers, record 20008845. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20008845

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.
PubMed
Journal
Clin Cancer Res
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
295
iCite
Relative citation ratio, by iCite
7.43
iCite
Revised in PubMed
2025-05-29
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Toole BPBryan P

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA073839NCI NIH HHSUnited StatesR01CA073839PubMed and NIHNIH RePORTER
R01 CA082867NCI NIH HHSUnited StatesR01CA082867PubMed and NIHNIH RePORTER

Download CSV of grants

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12680347Clinical uses of hyaluronan.Ciba Found Symp1989https://conductscience.org/library/papers/2680347PubMed
218691086The development of hyaluronan as a drug transporter and excipient for chemotherapeutic drugs.Curr Pharm Biotechnol2008https://conductscience.org/library/papers/18691086PubMed
318566232DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.Mol Cancer Ther2008https://conductscience.org/library/papers/18566232PubMed
414762695CD44v6: a target for antibody-based cancer therapy.Cancer Immunol Immunother2004https://conductscience.org/library/papers/14762695PubMed
518547053Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.Mol Pharm2008https://conductscience.org/library/papers/18547053PubMed
617591972Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells.Am J Pathol2007https://conductscience.org/library/papers/17591972PubMed
719279714Engineering a clinically-useful matrix for cell therapy.Organogenesis2008https://conductscience.org/library/papers/19279714PubMed
818450474Altered hyaluronan biosynthesis in cancer progression.Semin Cancer Biol2008https://conductscience.org/library/papers/18450474PubMed
99839618Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors.Cancer Lett1998https://conductscience.org/library/papers/9839618PubMed
1010871609Hyaluronan binding by cell surface CD44.J Biol Chem2000https://conductscience.org/library/papers/10871609PubMed
1117465836The role of hyaluronic acid in hemopoietic stem cell biology.Regen Med2006https://conductscience.org/library/papers/17465836PubMed
1219060478A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patients.Chemotherapy2009https://conductscience.org/library/papers/19060478PubMed
1317416541Alternative splicing in cancer: noise, functional, or systematic?Int J Biochem Cell Biol2007https://conductscience.org/library/papers/17416541PubMed
1417683255Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration.Expert Opin Drug Deliv2007https://conductscience.org/library/papers/17683255PubMed
1516061646The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.Cancer Res2005https://conductscience.org/library/papers/16061646PubMed
1616998484Targeting of CD44 eradicates human acute myeloid leukemic stem cells.Nat Med2006https://conductscience.org/library/papers/16998484PubMed
1718349857Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?Nat Clin Pract Oncol2008https://conductscience.org/library/papers/18349857PubMed
1818490190Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.Drug Resist Updat2008https://conductscience.org/library/papers/18490190PubMed
1919594639Immunological functions of hyaluronan and its receptors in the lymphatics.Immunol Rev2009https://conductscience.org/library/papers/19594639PubMed
2016998483Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells.Nat Med2006https://conductscience.org/library/papers/16998483PubMed

See all 68 referencesDownload CSV of references

Cited by177

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 295 citations.

PMIDTitleJournalYearIn PapersSource
42822349IGF2BP1 regulates chicken skeletal muscle development through an m6A-dependent inter-organ regulatory axis.Poult Sci2026https://conductscience.org/library/papers/42822349PubMed
42797312Evaluation of Histidine-Octamer-Modified Hyaluronic Acid as a Cytosolic Drug Delivery Material via CD44-Mediated Cellular Uptake and Endosomal Escape.Pharmaceutics2026https://conductscience.org/library/papers/42797312PubMed
42675095Nanoparticle-enhanced apigenin suppresses androgen receptor signaling and cellular plasticity in LNCaP cells.Sci Rep2026https://conductscience.org/library/papers/42675095PubMed
42509832Proteoglycans as Molecular Regulators of Bone Metastasis: Extracellular Matrix Remodeling, Tumor-Bone Crosstalk, Dormancy, and Therapeutic Opportunities.Biomolecules2026https://conductscience.org/library/papers/42509832PubMed
42453152Selective magnetic particle imaging of CD44 expressing cells using iron oxide nanoprobes functionalized with chemically modified hyaluronan.Nanoscale Adv2026https://conductscience.org/library/papers/42453152PubMed
42447444Glioblastoma Subtypes Exhibit Distinct Migration Mechanics and Immune Responses.Cancer Res Commun2026https://conductscience.org/library/papers/42447444PubMed
42144617Multitargeted nanoparticles inhibit cancer invasion by disrupting cancer-associated fibroblast-tumor cell crosstalk and modulating collagen pattern and EMT.J Nanobiotechnology2026https://conductscience.org/library/papers/42144617PubMed
41155434Hyaluronic Acid in Liver Fibrosis: Role in Inflammation, Tissue Remodeling, and Disease Progression.Int J Mol Sci2025https://conductscience.org/library/papers/41155434PubMed
40881990Molecular flexibility of hyaluronic acid has a profound effect on invasion of cancer cells.R Soc Open Sci2025https://conductscience.org/library/papers/40881990PubMed
40806330Targeting RHAMM in Cancer: Crosstalk with Non-Coding RNAs and Emerging Therapeutic Strategies Including Peptides, Oligomers, Antibodies, and Vaccines.Int J Mol Sci2025https://conductscience.org/library/papers/40806330PubMed
39594665Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials.Cells2024https://conductscience.org/library/papers/39594665PubMed
39239513Molecular imaging nanoprobes and their applications in atherosclerosis diagnosis.Theranostics2024https://conductscience.org/library/papers/39239513PubMed
38981928Investigation of the Circular Transcriptome in Alzheimer's Disease Brain.J Mol Neurosci2024https://conductscience.org/library/papers/38981928PubMed
38672650CD44: A New Prognostic Marker in Colorectal Cancer?Cancers (Basel)2024https://conductscience.org/library/papers/38672650PubMed
38542115Role of CD44 in Chemotherapy Treatment Outcome: A Scoping Review of Clinical Studies.Int J Mol Sci2024https://conductscience.org/library/papers/38542115PubMed
38169677Biomaterial-assisted local oxygenation safeguards the prostimulatory phenotype and functions of human dendritic cells in hypoxia.Front Immunol2023https://conductscience.org/library/papers/38169677PubMed
38089093Engineered In Vitro Tumor Model Recapitulates Molecular Signatures of Invasion in Glioblastoma.ACS Mater Au2023https://conductscience.org/library/papers/38089093PubMed
38026520Endogenous H2O2 Self-Replenishment and Sustainable Cascades Enhance the Efficacy of Sonodynamic Therapy.Int J Nanomedicine2023https://conductscience.org/library/papers/38026520PubMed
37958796The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer.Int J Mol Sci2023https://conductscience.org/library/papers/37958796PubMed
37761989Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases.Int J Mol Sci2023https://conductscience.org/library/papers/37761989PubMed

See all 177 cited byDownload CSV of cited by

Genes23

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB610058PubTator's text mininghttps://conductscience.org/library/genes/10058NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CD24100133941PubTator's text mininghttps://conductscience.org/library/genes/100133941NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
GAB12549PubTator's text mininghttps://conductscience.org/library/genes/2549NCBI Gene
GRB22885PubTator's text mininghttps://conductscience.org/library/genes/2885NCBI Gene
HABP23026PubTator's text mininghttps://conductscience.org/library/genes/3026NCBI Gene
HAS13036PubTator's text mininghttps://conductscience.org/library/genes/3036NCBI Gene
HAS33038PubTator's text mininghttps://conductscience.org/library/genes/3038NCBI Gene
HMMR3161PubTator's text mininghttps://conductscience.org/library/genes/3161NCBI Gene
LYVE110894PubTator's text mininghttps://conductscience.org/library/genes/10894NCBI Gene
NF24771PubTator's text mininghttps://conductscience.org/library/genes/4771NCBI Gene
PIK3R15295PubTator's text mininghttps://conductscience.org/library/genes/5295NCBI Gene
RAC15879PubTator's text mininghttps://conductscience.org/library/genes/5879NCBI Gene
RET5979PubTator's text mininghttps://conductscience.org/library/genes/5979NCBI Gene
RHOA387PubTator's text mininghttps://conductscience.org/library/genes/387NCBI Gene
SPP16696PubTator's text mininghttps://conductscience.org/library/genes/6696NCBI Gene
SRC6714PubTator's text mininghttps://conductscience.org/library/genes/6714NCBI Gene

See all 23 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20008845

GET https://conductscience.org/api/papers/v1/20008845/references?page=2